The International FOP Association is pleased to announce the 2017 Call for FOP Research Proposals.Read more
An important announcement from Clementia
The IFOPA is pleased to share this announcement from Clementia Pharmaceuticals: Top-line Results from Phase 2 Trial of Palovarotene for Treatment of Patients with FOP. Read more.
The National Organization for Rare Disorders (NORD) named Dr. Fred Kaplan among its 2017 honorees.